Replacement of dietary soy protein isolate with concentrates of soy 7S or 11S globulin has minimal or no effects on plasma lipoprotein profiles and biomarkers of coronary risk in monkeys


      Effects of soy peptide fractions on risk factors for coronary heart disease are unknown. We compared the effects of a soy protein isolate, a soy 7S fraction concentrate and a soy 11S fraction concentrate on total plasma cholesterol, HDL cholesterol, LDL + VLDL cholesterol and triacylglycerol in adult male cynomolgus monkeys. Effects on biomarkers of coronary risk [soluble E-selectin, vascular cell-adhesion molecule-1 (VCAM-1), monocyte chemoattractant protein-1 (MCP-1), transforming growth factor β-1 (TGF-β-1) and plasminogen activator inhibitor-1 (PAI-1)] were also determined. Relative to a soy- and isoflavone-free diet (casein and lactalbumin as the source of protein), soy protein isolate had the predicted favorable effects on plasma lipoproteins, i.e., reductions in total and VLDL + LDL cholesterol (8 and 14%, respectively) (P's < 0.05) and a 41% increase in HDL (P < 0.05). Effects of 7S and 11S on these variables were less favorable. In fact, there was a 7% increase in total plasma cholesterol concentration (P < 0.05) in monkeys fed 7S that was accounted for primarily by an increase in VLDL + LDL cholesterol. There was no effect of any protein source on cardiovascular biomarkers. Replacement of dietary soy protein isolate with concentrated 7S or 11S does not result in improvement of plasma lipoprotein profiles or cardiovascular biomarkers in monkeys.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Basu A.
        • Devaraj S.
        • Jialal I.
        Dietary factors that promote or retard inflammation.
        Arterioscler Thromb Vasc Biol. 2006; 26: 995-1001
        • Adams M.R.
        • Golden D.L.
        • Franke A.A.
        • Potter S.M.
        • Smith H.S.
        • Anthony M.S.
        Dietary soy β-conglycinin (7S globulin) inhibits atherosclerosis in mice.
        J Nutr. 2004; 134: 511-516
        • Lovati M.R.
        • Manzoni C.
        • Corsini A.
        • et al.
        Low density lipoprotein receptor activity is modulated by soybean globulins in cell culture.
        J Nutr. 1992; 122: 1971-1978
        • Lovati M.R.
        • Manzoni C.
        • Corsini A.
        • Granata A.
        • Fumagalli R.
        • Sirtori C.R.
        7S globulin from soybean is metabolized in human cell cultures by a specific uptake and degradation system.
        J Nutr. 1996; 126: 2831-2842
        • Sirtori C.R.
        • Even R.
        • Lovati M.R.
        Soybean protein diet and plasma cholesterol: from therapy to molecular mechanisms.
        Ann NY Acad Sci. 1993; 676: 188-201
        • Duranti M.
        • Lovati M.R.
        • Dani V.
        • et al.
        The α’ subunit from soybean 7S globulin lowers plasma lipids and upregulates liver β-VLDL receptors in rats fed a hypercholesterolemic diet.
        J Nutr. 2004; 134: 1334-1339
        • Lovati M.
        • Manzoni C.
        • Gianazza E.
        • et al.
        Soy protein peptides regulate cholesterol homeostasis in Hep G2 cells.
        J Nutr. 2000; 130: 2543-2549
        • Gianazza E.
        • Eberini I.
        • Arnoldi A.
        • Wait R.
        • Sirtori C.R.
        A proteomic investigation of isolated soy proteins with variable effects in experimental and clinical studies.
        J Nutr. 2003; 133: 9-14
        • Moriyama T.
        • Kishimoto K.
        • Nagai K.
        • et al.
        β-conglycinin diet suppresses serum triglyceride levels in normal and genetically obese mice by induction of β-oxidation, downregulation of fatty acid synthase and inhibition of triglyceride absorption.
        Biosci Biothechnol Biochem. 2004; 68: 352-359
        • Aoyama T.
        • Kohno M.
        • Saito T.
        • et al.
        Reduction by phytate-reduced β-conglycinin of plasma triglyceride level of young and adult rats.
        Biosci Biothechnol Biochem. 2001; 65: 1071-1075
        • St Clair R.W.
        • Anthony M.S.
        Soy, isoflavones and atherosclerosis.
        Handb Exp Pharmacol. 2005; 170: 301-323
        • Coward L.
        • Smith M.
        • Kirk M.
        • Barnes S.
        Chemical modification of isoflavones in soyfoods during cooking and processing.
        Am J Clin Nutr. 1998; 68: 1486S-1491S
        • Allain C.C.
        • Poon L.S.
        • Chan C.S.G.
        • Richmond W.
        • Fu P.C.
        Enzymatic determination of total serum cholesterol.
        Clin Chem. 1974; 20: 470-475
        • NHLBI
        Manual of laboratory operations: lipid research clinics program, vol. 1.
        NHLBI, NIH; DHEW publication NIH 75-268, Bethesda2004
        • Fossati P.
        • Principe L.
        Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide.
        Clin Chem. 1982; 28: 2077-2080
        • Baba T.
        • Ueda A.
        • Kohno M.
        • et al.
        Effects of soybean β-conglycinin on body fat ratio and serum lipid levels in healthy volunteers of female university students.
        J Nutr Sci Vitaminol. 2004; 50: 26-33
        • West S.G.
        • Hilpert K.F.
        • Juturu V.
        • et al.
        Effects of including soy protein in a blood cholesterol-lowering diet on markers of cardiac risk in men and in postmenopausal women with and without hormone replacement therapy.
        J Womens Health. 2005; 14: 253-262
        • Wagner J.D.
        • Schwenke D.C.
        • Greaves K.A.
        • et al.
        Soy protein with isoflavones, but not an isoflavone-rich supplement, improves arterial low density lipoprotein metabolism and atherogenesis.
        Arterioscler Thromb Vasc Biol. 2003; 23: 2241-2246
        • Blum A.
        • Lang N.
        • Peleg A.
        • et al.
        Effects of oral soy protein on markers of inflammation in postmenopausal women with mild hypercholesterolemia.
        Am Heart J. 2003; 145: e7
        • Hall W.L.
        • Vafeiadou K.
        • Hallund J.
        • et al.
        Soy isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production.
        Am J Clin Nutr. 2005; 82: 1260-1268
        • Steinberg F.M.
        • Guthrie N.L.
        • Villablanca A.C.
        • Kumar K.
        • Murray M.J.
        Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women.
        Am J Clin Nutr. 2003; 78: 128-130
        • Register T.C.
        • Cann J.A.
        • Kaplan J.R.
        • et al.
        Effects of soy isoflavones and conjugated equine estrogens on inflammatory markers in atherosclerotic, ovariectomized monkeys.
        J Clin Endocrinol Metab. 2005; 90: 1734-1740
        • Sanders T.A.B.
        • Dean T.S.
        • Grainger D.
        • Miller G.J.
        • Wiseman H.
        Moderate intakes of soy protein rich in isoflavones compared with ethanol-extracted soy protein increases HDL but do not influence transforming growth factor β1 concentrations and hemostatic risk factors for coronary heart disease in healthy subjects.
        Am J Clin Nutr. 2002; 76: 373-377
        • Atkinson C.
        • Oosthuizen W.
        • Scollen S.
        • Loktionov A.
        • Day N.E.
        • Bingham S.A.
        Modest protective effects of isoflavones from a red clover-derived dietary supplement on cardiovascular disease risk factors in perimenopausal women, and evidence of an interaction with ApoE genotype in 49-65 year-old women.
        J Nutr. 2004; 134: 1759-1764
        • Colacurci N.
        • Chiantera A.
        • Fornaro F.
        • et al.
        Effects of soy isoflavones on endothelial function in healthy postmenopausal women.
        Menopause. 2005; 12: 299-307
        • Masuda O.
        • Nakamura Y.
        • Takano T.
        Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats.
        J Nutr. 1996; 126: 3063-3068
        • Kitts D.D.
        • Weiler K.
        Bioactive proteins and peptides from food sources. Applications bioprocesses used in isolation and recovery.
        Curr Pharm Des. 2003; 9: 1309-1323
        • Jacoby D.S.
        • Rader D.J.
        Renin-angiotensin system and atherothrombotic disease. From genes to treatment.
        Arch Intern Med. 2003; 163: 1155-1164
        • Adams M.R.
        • Golden D.L.
        • Williams J.K.
        • et al.
        Soy protein containing isoflavones reduces the size of atherosclerotic plaques without influencing coronary artery reactivity.
        J Nutr. 2005; 135: 2852-2856